NCT03077919View on ClinicalTrials.gov

Effectiveness and Acceptability of Stellate Ganglion Block for Posttraumatic Stress Disorder Symptoms - Effectiveness

NACompletedINTERVENTIONAL
Enrollment

113

Participants

Timeline

Start Date

May 25, 2016

Primary Completion Date

June 9, 2018

Study Completion Date

June 9, 2018

Conditions
PostTraumatic Stress Disorder
Interventions
DRUG

Ropivacaine

0.5% ropivacaine

DRUG

Sham treatment

preservative-free normal saline

Trial Locations (3)

28310

Womack Army Medical Center (WAMC), Fort Bragg

66849

Landstuhl Regional Medical Center (LRMC), Landstuhl

96859

Tripler Army Medical Center (TAMC), Honolulu

All Listed Sponsors
collaborator

Womack Army Medical Center

FED

collaborator

Tripler Army Medical Center

FED

collaborator

Landstuhl Regional Medical Center

FED

lead

RTI International

OTHER

NCT03077919 - Effectiveness and Acceptability of Stellate Ganglion Block for Posttraumatic Stress Disorder Symptoms - Effectiveness | Biotech Hunter | Biotech Hunter